HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

V A Tkachuk Selected Research

urokinase inhibitor

3/2015Molecular modeling as a new approach to the development of urokinase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


V A Tkachuk Research Topics

Disease

7Neoplasms (Cancer)
11/2020 - 10/2001
4Neointima
01/2008 - 08/2000
3Neoplasm Metastasis (Metastasis)
11/2020 - 08/2017
3Vascular Remodeling
03/2015 - 01/2002
3Atherosclerosis
08/2004 - 01/2002
2Myocardial Infarction
09/2019 - 01/2013
1COVID-19
01/2021
1Neuroblastoma
11/2020
1Thrombosis (Thrombus)
09/2019
1Portal Hypertension
03/2019
1Vasculitis (Vasculitides)
03/2019
1Fibrosis (Cirrhosis)
03/2019
1Hemochromatosis (Bronze Diabetes)
03/2019
1Inflammation (Inflammations)
08/2017
1Basal Cell Carcinoma (Rodent Ulcer)
08/2017
1Psoriasis (Pustulosis Palmaris et Plantaris)
08/2017
1Autistic Disorder (Autism)
08/2016
1Language Disorders (Language Disorder)
08/2016
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2015
1Cardiovascular Diseases (Cardiovascular Disease)
01/2015
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2015
1Chronic Hepatitis C
01/2015
1Pathologic Processes
01/2014
1Insulin Resistance
01/2013
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2013
1Melanoma (Melanoma, Malignant)
07/2010
1Carcinogenesis
12/2008
1Necrosis
01/2006
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
01/2005
1Ischemia
05/2004
1Angina Pectoris
01/2002
1Coronary Restenosis
10/2001
1Pathologic Constriction (Stenosis)
05/2001
1Hypertension (High Blood Pressure)
01/2000

Drug/Important Bio-Agent (IBA)

9Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2020 - 08/2000
4Plasminogen Activators (Plasminogen Activator)IBA
05/2004 - 08/2000
3Proteins (Proteins, Gene)FDA Link
09/2019 - 08/2016
2Interleukin-6 (Interleukin 6)IBA
03/2019 - 01/2015
2Plasminogen Activator Inhibitor 1IBA
08/2017 - 01/2002
2H-cadherin (T-cadherin)IBA
01/2015 - 07/2010
2Hormones (Hormone)IBA
01/2013 - 01/2000
2Cadherins (E-Cadherin)IBA
12/2008 - 10/2001
1Urokinase Plasminogen Activator ReceptorsIBA
11/2020
1Pharmaceutical PreparationsIBA
09/2019
1FibrinolysinFDA Link
09/2019
1Antiviral Agents (Antivirals)IBA
03/2019
1CryoglobulinsIBA
03/2019
1urokinase inhibitorIBA
03/2015
1Interleukin-10 (Interleukin 10)IBA
01/2015
1AdiponectinIBA
01/2015
1Nitric Oxide Synthase (NO Synthase)IBA
01/2013
1Insulin (Novolin)FDA Link
01/2013
1GlycogenIBA
01/2013
1Glucose (Dextrose)FDA LinkGeneric
01/2013
1Gap Junction alpha-4 ProteinIBA
01/2013
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2013
1matrigelIBA
12/2008
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2008
1Acetylcysteine (Siran)FDA LinkGeneric
12/2008
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2008
1AntioxidantsIBA
12/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2006
1Matrix Metalloproteinases (MMPs)IBA
03/2005
1Ventricular MyosinsIBA
01/2005
1oxidized low density lipoproteinIBA
08/2004
1CholesterolIBA
08/2004
1IntegrinsIBA
10/2001
1Tissue Plasminogen Activator (Alteplase)FDA Link
05/2001
1Poloxamer (Poloxamer 407)IBA
05/2001

Therapy/Procedure

1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2021
1Catheters
05/2001